Welcome to our dedicated page for Avepoint SEC filings (Ticker: AVPT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The AvePoint, Inc. (AVPT) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures, including current reports on Form 8-K and other key documents filed with the U.S. Securities and Exchange Commission. These filings offer detailed information about AvePoint’s financial results, capital markets activity, and material corporate events related to its role as a provider of data security, governance, and resilience solutions for SaaS and cloud collaboration platforms.
Investors can use AvePoint’s 8-K filings to review press releases that are furnished as exhibits, such as quarterly financial results and announcements about underwriting agreements and public offerings connected to the company’s listing on the Singapore Exchange. For example, AvePoint has filed Form 8-K reports to furnish its second and third quarter financial results and to disclose the underwriting agreement and offering terms associated with its SGX listing. These documents complement the company’s annual and quarterly reports on Forms 10-K and 10-Q, which contain broader discussions of financial condition, risk factors, and business operations.
The filings page also reflects corporate actions related to listing status. A Form 25 filing, for instance, documents the removal from listing and registration on Nasdaq of a class of AvePoint warrants under Section 12(b) of the Securities Exchange Act of 1934. Such filings help investors understand changes in how specific AvePoint securities trade and are registered.
On Stock Titan, AvePoint filings are paired with AI-powered summaries that explain the significance of each document in clear language. Users can quickly see the main points of earnings-related 8-Ks, offerings, and listing changes, while still having direct access to the full text on EDGAR. This combination of real-time updates, insider-relevant forms such as 8-K and 25, and AI-generated insights helps investors and analysts follow AvePoint’s regulatory history and ongoing disclosure practices more efficiently.
AvePoint, Inc. (AVPT) furnished an 8-K announcing it issued a press release reporting financial results for the third quarter ended September 30, 2025. The press release is attached as Exhibit 99.1 and the information under Item 2.02 is being furnished, not filed, under the Exchange Act.
AvePoint, Inc. (AVPT) insider filing shows Executive Chairman and Director reported open‑market sales of common stock on two dates. On 11/03/2025, 41,679 shares were sold at $13.96 per share. On 11/04/2025, 18,321 shares were sold at $13.80 per share.
The transactions were made under a Rule 10b5-1 trading plan adopted on June 22, 2025. Following these sales, the reporting person beneficially owned 15,040,668 shares indirectly, held by various trusts and LLCs for which he is affiliated or acts as trustee.
AvePoint (AVPT) reported an insider transaction by its Director and Chief Legal Officer. On October 24, 2025, the reporting person sold 1,848 shares of common stock at $15.03 per share under a Rule 10b5-1 plan adopted on December 18, 2024. Following the sale, the reporting person beneficially owned 631,893 shares, held directly. Beneficial ownership includes non‑RSU shares and RSUs subject to previously disclosed vesting schedules.
AvePoint (AVPT) disclosed an insider transaction by its Chief Executive Officer and director on 10/17/2025. The reporting person exercised stock options and acquired common shares in three transactions: 299,435, 158,634, and 37,974 shares, at exercise prices of
The holdings reflect common stock and restricted stock units granted under AvePoint’s equity incentive plans, as noted in the footnotes.
AvePoint (AVPT) filed an amended Form 4 reporting that its Chief Executive Officer and Director exercised multiple stock option tranches on 10/13/2025 under the 2016 Equity Incentive Plan. The amendment adds these specific tranches to the prior filing.
The transactions (code M) cover options for 569,707 shares at an exercise price of $1.34, 362,850 shares at $1.59, and 1,716,047 shares at $3.91, each into common stock. Following these entries, the reported remaining derivative securities beneficially owned declined sequentially to 3,000,104, with ownership shown as Direct. Table I reflects no separate non-derivative share transactions in this excerpt.
AvePoint, Inc. (AVPT) CEO and Director reported an insider transaction. On 10/15/2025, the reporting person transferred 1,542,779 shares of common stock from direct ownership to River Valley Ltd. in connection with a loan repayment totaling $22,542,001, reported as a change in the form of ownership (Code J). The transaction carried a reported price of $14.61 per share.
Following the transaction, direct beneficial ownership was 1,657,459 shares. Indirect beneficial ownership was 15,384,632 shares, held by trusts and LLCs as noted. Footnotes state indirect holdings include shares at entities affiliated with or overseen by the reporting person.
AvePoint (AVPT) reported insider transactions by its Chief Executive Officer and Director on 10/13/2025. The reporting person exercised stock options (transaction code M) and acquired common stock (coded A) at an exercise price of $14.61 per share in three tranches of 569,707, 362,850, and 1,716,047 shares. Following these transactions, the reporting person directly beneficially owned 3,200,238 shares. The filing notes these holdings include vested and unvested RSUs granted under the company’s equity plans.
AvePoint, Inc. (AVPT) director and Executive Chairman Gong Xunkai reported two scheduled stock sales under a Rule 10b5-1 trading plan adopted on
The filing notes the sales were effected pursuant to the pre-established trading plan and disclaims direct beneficial ownership of trust and LLC holdings except to the extent of pecuniary interest. The form was signed by an attorney-in-fact on
AvePoint, Inc. director and Executive Chairman Xunkai Gong reported a sale of 31,950 shares of common stock on 09/29/2025 at $15.34 per share under a Rule 10b5-1 trading plan adopted on 06/22/2025. The filing shows Mr. Gong beneficially owns 15,188,718 shares following the sale, held indirectly through several trusts and LLCs (Giocoso Holdings LLC, Cadenza Holdings LLC, Vivace Holdings LLC, The Purple Harbor Trust, The Purple Cove Trust, and G Sonata Trust). The report states he disclaims beneficial ownership of trust/LLC shares except to the extent of his pecuniary interest.
The transaction was reported on Form 4 and was executed pursuant to a pre-established trading plan, indicating the sale was planned rather than opportunistic based on undisclosed material information.
A holder of AvePoint, Inc. (AVPT) filed a Form 144 announcing a proposed sale of 240,000 Common Class A shares through The Charles Schwab Corporation. The filing lists an aggregate market value of $3,705,600 and shows approximately 211,926,808 shares outstanding, with an approximate sale date of 09/29/2025 on NASDAQ. The shares were acquired as founders shares from the issuer on 01/02/2006, and the filer reports no securities sold in the past three months.